European Gonococcal Antimicrobial Surveillance Programme: external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing
An EQA scheme for Neisseria gonorrhoeae antimicrobial susceptibility was established in 2007 as part of the European Surveillance to STIs programme. The EQA scheme is available for all participating laboratories in the STI surveillance network. An EQA scheme is an essential component of a laboratory-based surveillance programme; ensuring comparability of data between and within testing centres and successful performance in EQA is a requirement for laboratories participating in de-centralised testing as part of antimicrobial resistance (AMR) surveillance across Europe.
The laboratories participating in the EQA scheme for susceptibility testing of N. gonorrhoeae showed good levels of competence and capability on the whole in isolating and testing strains of unknown phenotype
Molecular typing of Neisseria gonorrhoeae – a study of 2013 isolates
16 May 2018 - This report describes the second molecular typing survey of N. gonorrhoeae across the EU/EEA and provides recent information on NG-MAST STs/Gs and genotypes based on WGS circulating in 21 EU/EEA Member States.
European Gonococcal Antimicrobial Surveillance Programme external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing, 2017
27 Oct 2017 - An EQA scheme for antimicrobial susceptibility testing in Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This is the third EQA to be published on antimicrobial susceptibility testing in Neisseria gonorrhoeae.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2015
24 Aug 2017 - The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) follows a decentralised and centralised testing model. In 2015, 24 EU/EEA Member States participated in Euro-GASP, 17 through decentralised testing.